IL6 and neurodegenerative disease: Under pathological conditions such as stress, infection, or neurodegenerative diseases, pro-inflammatory cytokines, including tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6), are released in excess [13].